Lavipharm
From Wikipedia, the free encyclopedia
 | |
| Company type | S.A. |
|---|---|
| ATHEX was Lavi | |
| Founded | 1911 |
| Headquarters | Athens, Greece |
Key people | Telemaque Lavidas (CEO) |
| Products | pharmaceutical, cosmetic, veterinary & Consumer health products |
| Revenue | €61,001,000 (2024) |
| €25,080,000 (2024) | |
| Footnotes / references [1] | |
Lavipharm S.A. is the largest integrated Greek pharmaceutical company that develops, manufactures, markets and distributes pharmaceutical, cosmetic, veterinary and consumer health products in Greece and internationally (France, Cyprus and the United States). It was founded in 1911, by the Lavidas’ family, and listed on the Athens Stock Exchange in 1995.[2]
